Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker forAlzheimer's disease

Citation
K. Ishiguro et al., Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker forAlzheimer's disease, NEUROSCI L, 270(2), 1999, pp. 91-94
Citations number
11
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
270
Issue
2
Year of publication
1999
Pages
91 - 94
Database
ISI
SICI code
0304-3940(19990730)270:2<91:PTIHCF>2.0.ZU;2-7
Abstract
Microtubule-associated protein tau in cerebrospinal fluid (CSF) has been pr oposed as a diagnostic marker for Alzheimer's disease (AD), but there is ov erlap between AD patients and non-AD controls. To improve the diagnostic ac curacy, we measured phosphorylated tau in CSF, because phosphorylated tau a ccumulates as pathological paired helical filaments in neurons of the AD br ain. Immunoblot showed that CSF contained a 32 kDa N-terminal fragment of t au that was partially phosphorylated on Ser199, Thr231 and Ser235. A sandwi ch enzyme immunoassay revealed that phosphorylated CSF-tau levels were sign ificantly higher in AD patients than those in non-AD controls. Discriminati on between the two groups was clearer in phosphorylated CSF-tau than in tot al CSF-tau. The data indicate that elevated phosphorylated CSF-tau level is a more specific diagnostic marker for AD. (C) 1999 Elsevier Science Irelan d Ltd. All rights reserved.